128
PERGUNTAS & RESPOSTAS
RETINOPATIA DIABÉTICA - Novo Paradigma de Cuidados
Perspectivas futuras em relação à terapêutica combinada
Novas terapêuticas se perfilam para tratamento da retinopa-
tia diabética à medida que são conhecidos os resultados de novos
estudos como o FAME e DA VINCI
31
.
No entanto tal como acima
referido, tendo em conta a natureza multifactorial da retinopatia dia-
bética, as terapêuticas combinadas parecem ter a priori, um forte
racional para a sua utilização. ( Ver questão nº 25)
Bibliografia
1.
Early Treatment Diabetic Retinopathy Study Research Group. Photocoa-
gulation for diabetic macular edema. Early Treatment Diabetic Retinopa-
thy Study Report no. 1. Arch Ophthalmol 1985;103:1796–1806.
2.
Moss SE, Klein R, Klein BE. Ten-year incidence of visual loss in a diabetic
population. Ophthalmology 1994;101:1061–70.
3.
Augustin A. Desta forma consegue-se uma melhor resposta terapêutica
e Triple therapy for age-related macular degeneration. Retina 2009;29(6
Suppl):8-11.
4.
Kang SW, Park SC, Cho HY, Kang JH. Triple therapy of vitrectomy, intra-
vitreal triamcinolone, and macular laser photocoagulation for intractable
diabetic macular edema. Am J Ophthalmol 2007;144(6):878-885.
5.
Lee CM, Olk RJ. Modified grid laser photocoagulation for diffuse diabetic
macular edema. Long-term visual results. Ophthalmology 1991;98:1594–
1602.
6.
Lee CM, Olk RJ. Modified grid laser photocoagulation for diffuse diabetic
macular edema. Long-term visual results. Ophthalmology 1991;98:1594–
1602.
7.
Bresnick GH. Diabetic maculopathy: a critical review highlight- ing diffu-
se macular edema. Ophthalmology 1983;90:1301–1317.
8.
Funatsu H, Yamashita H, Nakamura S, et al. Vitreous levels of pigment
epithelium-derived factor and vascular endothelial growth factor are rela-
ted to diabetic macular edema. Ophthalmology 2006;113:294–301.
9.
Yilmaz T, Weaver CD, Gallagher MJ, et al. Intravitreal triamcinolone ace-
tonide injection for treatment of refractory diabetic macular edema: a
systematic review. Ophthalmology. 2009;116(5):902-911.
10.
Toda J, Fukushima H, Kato S. Injection of triamcinolone acetonide into
the posterior sub-tenon capsule for treatment of diabetic macular edema.
Retina 27(6):764-769.
11.
Campochiaro P a, Brown DM, Pearson A, et al. Sustained Delivery Fluo-
cinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in
Patients with Diabetic Macular Edema. Ophthalmology 2012; 119:(10)
:2125-2132.